Anacor Pharmaceuticals to Present at Upcoming Investor Conferences MarketWatch (press release) Anacor is also nonindustrial AN2718 as a topical antifungal product candidate for the treatment of onychomycosis and skin fungal infections and AN2898 as type A topical anti-inflammatory product nominee for the treatment of psoriasis and atopic dermatitis. and more » Link To Article
No comments:
Post a Comment